Delivery Order SPE2DB22D3004-SPE2DB25FPU67

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,464,440 units of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,737.24 and an ultimate completion date of December 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a $4,993.14 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,056,293 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of July 3, 2024 and was awarded on July 2, 2022. This delivery order is part of a larger Indefinite...
This is a firm-fixed-price delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,118,096 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The total ceiling value of the contract is $1,372.92, with a period of performance running through February 3, 2025. This award is not designated as a set-aside contract....
This federal contract award, valued at $1,039.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,830,894 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used to treat opioid overdoses. The contract is a Delivery Order with a Firm Fixed Price, with a completion date of May 5, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,999.85, is for the delivery of 4,563,244,442 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 8, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of 4,560,715,310 units of Naloxone HCl 4 mg Nasal Spray. The delivery order, valued at $3,008.61, has a firm fixed price and will be completed by April 26, 2023. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,131,816 units of Naloxone HCL 4 mg Nasal Spray, with an ultimate completion date of December 19, 2023 and a ceiling value of $3,702.66. The contract is a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,324,180 units of Naloxone HCL 4 mg Nasal Spray, an opioid overdose reversal medication. The contract has a ceiling value of $8,728.30 and a period of performance through January 16, 2024. The contract was awarded on a firm fixed-price basis and was not subject to any set-aside requirements. Amerisourcebergen Drug...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of 4,561,027,452 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The award, valued at $2,931.70, has a firm fixed-price structure and an ultimate completion date of May 24, 2023. This contract is not set aside for any specific business type....
This federal contract award, valued at $1,211.88, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,450,464 units of Naloxone HCL 4 mg Nasal Spray, with an ultimate completion date of November 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPU67
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,486,292 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $20,243.49 and a completion date of March 7, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded without any set-aside designation, indicating open competition.

Generated 6/5/25, 9:45 AM